Hematology is the diagnostic classification of blood cells and consequent identification of blood diseases and diseases of the blood-forming organs. This includes the counting of red and white blood cells and platelets. The testing for hematologic disorders is relevant in screening, diagnosis, prognosis and disease monitoring.
Roche is committed to hematology and integrated laboratory solutions with innovative products which deliver medical value to our customers and patients.
In 2013 Roche acquired Constitution Medical Investors, Inc. (CMI), based in Boston Massachusetts (USA). CMI is the developer of a highly innovative hematology testing system, the cobas m 511 which is designed to provide faster and more accurate diagnosis of blood-related diseases, thereby improving patient care. The BloodhoundTM technology is the core of a fully-automated system with the capability to increase efficiency and save laboratory space by integrating hematology analyser, slide maker and stainer and morphology analyzer into a single, compact unit.